期刊文献+

CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME WITH RISING BLOOD SUGAR

CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME WITH RISING BLOOD SUGAR
下载PDF
导出
摘要 Objective To report one case of neuroleptic malignant syndrome (NMS) with raising blood sugar. Methods The patient was studied clinically with biochemistry, white blood cells, psychiatric symptoms, and creatine phosphokinase (CPK) observations. Results The male patient with a history of taking antipsychotics more 30 years and his age of onset was about 20 years. He had severe muscular rigidity, altered consciousness and autonomic disturbance associated with elevation of serum CPK levels (max 3755 U/L) and leucocytosis(max 13.3×10 9 /L), especially granular leukocytosis( max 90%) and lymphocytopenia (min 8%). In addition, high blood sugar emerged along with the variation of white blood cells (max 9.0 mmol/L). Conclusion The manifestations of the patient was in conformity with those of the NMS. The patient had catatonic signs such as mutism, drinking difficulty, etc. and excess of saliva. Developmental observation with CPK and white blood cells is able to reveal the severity level of NMS. Raising blood sugar should be also monitoring item. Objective To report one case of neuroleptic malignant syndrome (NMS) with raising blood sugar. Methods The patient was studied clinically with biochemistry, white blood cells, psychiatric symptoms, and creatine phosphokinase (CPK) observations. Results The male patient with a history of taking antipsychot- ics more 30 years and his age of onset was about 20 years. He had severe muscular rigidity, altered consciousness and autonomic disturbance associated with elevation of serum CPK levels (max 3755 U/ L ) and leucocytosis (max 13.3 × 10^9/L), especially granular leukocytosis( max 90% ) and lymphocytopenia (rain 8% ). In addition, high blood sugar emerged along with the variation of white blood cells ( max 9. 0 mmol/L). Conclusion The manifestations of the patient was in conformity with those of the NMS. The patient had catatonic signs such as mutism, drinking difficulty, etc. and excess of saliva. Developmental observation with CPK and white blood cells is able to reveal the severity level of NMS. Raising blood sugar should be also monitoring item.
出处 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2007年第1期69-74,F0003,共7页 上海第二医科大学学报(英文版)
关键词 精神安定药 综合症 血糖 药物治疗 neuroleptic malignant syndrome white blood cell creatine phosphokinase blood sugar
  • 相关文献

参考文献12

  • 1M.U. Gerbershagen,M. Fiege,T. Krause,K. Agarwal,F. Wappler.Dantrolen[J].Der Anaesthesist.2003(3)
  • 2G. Northoff.Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology[J].Journal of Neural Transmission.2002(12)
  • 3Kawanishi C.Genetic predisposition to neuroleptic malignant syn- drome: implications for antipsychotic therapy[].Am J Pharmacog- enomics.2003
  • 4Stanley AK,Hunter J.Possible neuroleptic malignant syndrome with quetiapine[].Br J Psychiatry.2000
  • 5Peiris DTS,Kuruppuarachchi K,Weerasena LP, etal.neurolep- tic malignant syndrome without fever: a report of three cases[].J Neurol Neurosurg Psychiatry.2000
  • 6Hasan S,Buckley P.Novel antipsychotics and neuroleptic ma- lignant syndrome: a review and critique[].Am J Psychiatry.1998
  • 7Nemeroff CB,Schatzberg AF.The American Psychiatric Press textbook of psychopharmacology[]..1998
  • 8Schatzberg AF,Nemeroff CB.The American psychiatric press: textbook of psychopharmacology[]..1998
  • 9Schatzberg AF,Nemeroff CB.The American psychiatric press: textbook of psychopharmacology[]..1998
  • 10Bottlender R,Jager M,Hofschuster E, et al.Neuroleptic malig- nant syndrome due to atypical neuroleptics: three episodes in one patient[].Pharmacopsychiatry.2002

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部